| Dr Sandra Matano, MD | |
|
760 Broadway, Brooklyn, NY 11206-5317 | |
| (718) 963-8583 | |
| Not Available |
| Full Name | Dr Sandra Matano |
|---|---|
| Gender | Female |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | 760 Broadway, Brooklyn, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578700589 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 232260 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sandra Matano, MD 760 Broadway, Brooklyn, NY 11206-5317 Ph: (718) 963-8583 | Dr Sandra Matano, MD 760 Broadway, Brooklyn, NY 11206-5317 Ph: (718) 963-8583 |
News Archive
Biovision, the annual forum devoted to future-oriented research in life sciences, is launching this years' registration campaign and its call for applications for innovative projects and companies. This year's event will take place in Lyon, France, on June 5 and 6, 2014.
Kaiser Health News staff writer Julie Appleby reports: "One of the nation's largest health insurers said today it is testing a new way to pay for some cancer treatments, aiming to identify the best medicines - and limit profits doctors make by dispensing in-office chemotherapy drugs" (Appleby, 10/20).
The greater the reduction in LDL (lower-density lipoprotein) cholesterol achieved by statin therapy the greater the reduction in incidence of major coronary events, coronary revascularisation and stroke, concludes a meta-analysis published online today by The Lancet.
A new study posted to the medRxiv* server and led by Dr. Mattia D'Agostino, Dr. Eleonora Pavoni and Dr. Alice Romagnoli from the Polytechnic University of Marche in Ancona (Italy), a gFET biosensor that uses angiotensin-converting enzyme 2 (ACE2) as a bioreceptor has been put forth as a viable solution.
Genzyme, a Sanofi company, announced today the European Medicines Agency (EMA) has accepted the filing of the marketing authorization application (MAA) for once-daily oral teriflunomide for the treatment of relapsing forms of multiple sclerosis (MS).
› Verified 4 days ago
Mrs. Elena Agranovsky, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 1857 86th St, Brooklyn, NY 11214 Phone: 718-232-1515 Fax: 718-232-1550 | |
Dr. Charles Y. Shao, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 450 Clarkson Ave, Box 25, Brooklyn, NY 11203 Phone: 718-270-6755 Fax: 718-270-3313 | |
Irina Meisher, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 2601 Ocean Pkwy, Brooklyn, NY 11235 Phone: 718-616-4408 Fax: 718-616-4105 | |
Mr. Archinto Peter Anzil, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 943 President St, Brooklyn, NY 11215 Phone: 718-622-4482 | |
Anne-marie Desrosiers, Pathology Medicare: Not Enrolled in Medicare Practice Location: 1545 Atlantic Ave, Brooklyn, NY 11213 Phone: 718-613-4000 | |
Dr. Hongbei Wang, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 450 Clarkson Avenue, Department Of Pathology, Box 25, Brooklyn, NY 11203 Phone: 718-270-4522 | |
Kathleen Rose Mccubbin, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 599 Winthrop St, Brooklyn, NY 11203 Phone: 718-604-4464 |